Clinical trial
A Comparative Bioavailability Study of Fluoxetine Hydrochloride Capsules, 40 mg
NCT00947076 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Bioavailability Study of Fluoxetine Hydrochloride Capsules, 40 mg
- Lead sponsor
- Sandoz
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2001
- Completion date
- April 30, 2001
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
depression